Abarca Health And LucyRx To Merge Into Alternative To Big Three PBMs

Key Points:

• Abarca Health and LucyRx, two independent pharmacy benefit managers (PBMs), have agreed to merge, creating a company serving over 9 million plan members across the U.S. and positioning it among the top 10 PBMs by prescription volume.
• The merger aims to offer a transparent alternative to the three largest PBMs—CVS Health’s Caremark, Express Scripts (Cigna), and OptumRx (UnitedHealth Group)—which dominate 80% of the market and face scrutiny over conflicts of interest and anticompetitive behavior.
• Both companies emphasize the need for greater competition and flexibility in the PBM market amid rising drug costs, regulatory changes, and demand for improved transparency and affordability from employers and consumers.
• After closing in the third quarter, Abarca and LucyRx will operate as wholly owned subsidiaries of Healthcare Revolution Partners, retaining their brands and leadership while expanding their reach to all 50 states with complementary client bases.
• The combined entity plans to leverage advanced technology and clinical capabilities to enhance customer experience and cost savings, continuing initiatives like Abarca’s involvement in Blue Shield of California’s partnership with Amazon Pharmacy.